Abstract

Tyrosine kinase inhibitors (TKIs) such as sunitinib that target vascular endothelial growth factor (VEGF) are widely used and are frequently active in

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call